Company Financials

Vera Therapeutics, Inc. Financials

United States dollar

business Vera Therapeutics, Inc. Company Profile

Main Stock Listing

NASDAQ: VERA

Market Capitalization $3.45 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -17.68
Forward PE -11.20
Price to Sales TTM $
Price to Book MRQ $8.11
Enterprise to Revenue
Enterprise to EBITDA -10.44

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 0.00%
Operating Margin 0.00%
Return on Assets TTM -38.12%
Return on Equity TTM -73.25%

Income Statement

Revenue TTM $0
Revenue per Share TTM $0.00
Quarterly Revenue Growth %
Gross Profit TTM $0
EBITDA $-269,792,992
Net Income to Common TTM $-251,943,008
Diluted EPS TTM $-3.99
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $497,388,992
Total Cash per Share MRQ $7.78
Total Debt MRQ $
Total Debt to Equity MRQ 19.36
Current Ratio MRQ 12.21
Book Value per Share MRQ $6.24

Cash Flow

Operating Cash Flow TTM $-210,292,000
Levered Free Cash Flow TTM $-127,441,376

VERA Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 63,894,845
Float Shares 46,032,682
Avg 10 Volume 1,125,130
Avg 30 Volume None
Shares Short 9,145,275
Short Ratio 4.82
Short % of Shares 14.62%
% Held by Insiders 0.88%
% Held by Institutions 103.29%

Stock Price Summary

Beta 1.21
Fifty Two Week Low $18.53
Fifty Two Week High $56.05
Fifty Two Week Change 13.08%
Day 50 MA $36.97
Day 200 MA $27.07

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date